FMP
PolyPid Ltd.
PYPD
NASDAQ
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
4.43 USD
-0.065 (-1.47%)
About
ceo
Ms. Dikla Czaczkes Akselbrad
sector
Healthcare
industry
Biotechnology
website
https://www.polypid.com
exchange
NASDAQ
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
CIK
0001611842
ISIN
IL0011326795
CUSIP
M8001Q118
Address
18 Hasivim Street
Phone
972 7 4719 5700
Country
IL
Employee
59
IPO Date
Jun 26, 2020
Summary
CIK
0001611842
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
M8001Q118
ISIN
IL0011326795
Country
IL
Price
4.42
Beta
1.41
Volume Avg.
3.34k
Market Cap
7.32M
Shares
-
52-Week
3.566-13.5
DCF
-4.39
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.26
P/B
-
Website
https://www.polypid.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PYPD News
It looks like there's no news available.
